UnknownNot applicableNCT03813134

Testing the Value of Novel Strategy and Its Cost Efficacy in Order to Improve the Poor Outcomes in Cardiogenic Shock

Studying Cardiogenic shock

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Leicester
Principal Investigator
Anthony H Gershlick
University of Leicester
Intervention
Percutaneous coronary intervention (PCI)(procedure)
Enrollment
428 enrolled
Eligibility
18-90 years · All sexes
Timeline
2019 – 2024

Study locations (30)

Collaborators

European Commission · University of Glasgow · KU Leuven · University of East Anglia · Deutsches Herzzentrum Muenchen · A.O. Ospedale Papa Giovanni XXIII · Chalice Medical Ltd · Ludwig-Maximilians - University of Munich · University of Tromso · Institut d'Investigacions Biomèdiques August Pi i Sunyer · Paula Stradina Liniska Universitates · Accelopment AG · Universiteit Antwerpen · European Cardiovascular Research Center

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03813134 on ClinicalTrials.gov

Other trials for Cardiogenic shock

Additional recruiting or active studies for the same condition.

See all trials for Cardiogenic shock →

← Back to all trials